Pfizer
Tina Cipollari has over 25 years of experience in clinical operations and project management within the pharmaceutical industry. At Pfizer, serving as Senior Director and Clinical Study Team Lead from August 1995 to April 2021, Tina was responsible for the oversight and delivery of Phase I Oncology trials, ensuring operational accountability from concept to regulatory submission. Prior to Pfizer, Tina held various positions at Purdue Pharma, including Associate Director of Clinical Operations and Clinical Compliance, from September 2012 to April 2017. Tina holds a Bachelor's degree in English and Education from the University at Albany, where studies were completed from January 1987 to January 1991.
This person is not in any teams
This person is not in any offices
Pfizer
614 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.